期刊文献+

SEANIR监测中国15所教学医院不发酵糖革兰阴性杆菌对13种抗菌药物的药敏试验 被引量:8

Antimicrobial susceptibilitytesting of non-fermentative bacteria in 15 teaching hospitals in China:a report from SEANIR antimicrobial resistance surveillance 2008
下载PDF
导出
摘要 目的分析SEANIR监测2008年中国15所教学医院医院获得性不发酵糖革兰阴性杆菌对抗菌药物的敏感性,并评价帕尼培南体外药敏试验方法。方法收集2008年分离自中国15所教学医院医院获得性感染患者的非重复鲍曼不动杆菌349株、铜绿假单胞菌359株、嗜麦芽窄食单胞菌145株和洋葱伯克霍尔德菌100株,用琼脂稀释法测定13种抗菌药物的MIC,对比MH培养基和1:40 MH培养基对帕尼培南药敏试验结果的影响。结果鲍曼不动杆菌对碳青霉烯类抗生素的敏感率仅为51.6%~63.7%;多黏菌素B和米诺环素对鲍曼不动杆菌的体外抑菌活性最强,且对亚胺培南耐药鲍曼不动杆菌仍具有较高的抑菌率(分别98.1%和72.8%)。多黏菌素B和阿米卡星对铜绿假单胞菌的抑菌率最高(分别为96.1%和83.3%),其次为用1:40 MH培养基测定帕尼培南、哌拉西林-他唑巴坦和美罗培南的抑菌率(72.4%~77.2%)。嗜麦芽窄食单胞菌和洋葱伯克霍尔德菌对米诺环素和甲氧苄啶-磺胺甲噁唑均较敏感(敏感率为78.6%~98.0%)。结论多黏菌素B对鲍曼不动杆菌和铜绿假单胞菌,米诺环素对鲍曼不动杆菌、嗜麦芽窄食单胞菌和洋葱伯克霍尔德菌,具有较强的体外抗菌活性。帕尼培南的体外药敏试验,鲍曼不动杆菌应采用MH培养基测定,铜绿假单胞菌应采用1:40 MH培养基测定,其抗菌作用与亚胺培南较为接近。 susceptibility was determined by agar dilution method. Both MH and 1 : 40 MH medium were used when testing the suscepti- bility to panipenem. Results The percentage of A. baumannii susceptible to carbapenems ranged frona 51.6% to 63.7%. Poly- myxin B and minocycline showed the highest antimicrobial activity against A. baumannii. Even for the imipenem-resistant A. baumannii, there were still 98.1% and 72.8% of the strains susceptible to polymyxin B and minoeycline. Polymyxin B and amikacin were the most active antibiotics against P. aeruginosa (96.1 % and 83.3% susceptible, respectively), followed by pa- nipenem determined with 1 : 40 MH, piperacillin-tazobactam and meropenem (72.4% to 77.2% susceptible). Minocycline and trimethoprim-sulfamethoxazole were the most active antibiotics against S. maltophilia and B. cepacia (78.6% to 77.2% sus- ceptible). Conclusions Polymyxin B showed the highest antimicrobial activity against A. baurnannii and P. aeruginosa. Mino- eycline was most active against A. baumannii, S. rnaltophilia and B. cepacia. MH medium should be used when testing the antimicrobial susceptibility of A. baumannii to panipenem, but for P. aeruginosa the 1 : 40 MH should be used.
出处 《中国感染与化疗杂志》 CAS 北大核心 2012年第4期268-275,共8页 Chinese Journal of Infection and Chemotherapy
关键词 不发酵糖革兰阴性杆菌 抗菌药物敏感性 耐药监测 帕尼培南 non-fermentative gram-negative bacterium antimicrobial susceptibility antimicrobial resistance surveillance panipenem
  • 相关文献

参考文献13

  • 1Igari J. In vitro antimicrobial activity of carbapenem antibiotics against Pseudomonas aeruginosa, measured using a low- concentration Mueller-Hinton agar culture medium[J]. Jpn J Antibiot, 1999,52(6):449-457.
  • 2Clinical and Laboratory Standards Institute. Methods for dilu tion antimicrobial susceptibility tests for bacteria that grow aerobically[S], approved standard-eighth edition. M07-AS: 2009.
  • 3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S], twenty first informational supplement. M100-S21: 2011.
  • 4杨启文,徐英春,陈民钧,胡云建,倪语星,孙景勇,俞云松,孔海深,何林,吴伟元,叶惠芬,杨银梅,朱莲娜,郭世辉,季萍,朱震宏,任健康,张利侠,孙自镛,朱旭慧,童明庆,赵旺胜,梅亚宁,刘勇,张智洁,段琼,李丹,刘蓬蓬,王晶,韩丽霞,王辉,谢秀丽.2005年中国十五家教学医院院内获得革兰阴性病原菌耐药性分析[J].中华医学杂志,2007,87(39):2753-2758. 被引量:34
  • 5Karageorgopoulos DE, Falagas ME. Current control and treatment of muhidrug resistant Acinetobacter baumannii infections[J]. Lancet Infect Dis, 2008,8(12) :751-762.
  • 6Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals[J]. Antimicrob Agents Chemother, 2007,51(11) :4022-4028.
  • 7Rodriguez-Martlnez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonasaeruginosa[J]. Antimicrob Agents Chemother, 2009,53 (11) : 4783-4788.
  • 8Fukuoka T, Ohya S, Narita T, et al. Activity of the carbap enem panipenem and role of the OprD (D2) protein in its diffusion through the Pseudomonas aeruginosa outer membrane [J]. Antimicrob Agents Chemother, 1993,37(2) :322-327.
  • 9Muramatsu H, Horii T, Mori:a M, et al. Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates [J]. Int J Med Microbiol, 2003, 293(2-3): 191-197.
  • 10Hara K,Kouno SKH, Takebe K, et al. A comparative study of panipenem/betamipron and imipenem/cilastatin in respira- tory tract infections [ J ]. Chemotherapy, 1992,40 ( 5 ) : 613- 637.

二级参考文献26

共引文献49

同被引文献73

  • 1史文元,吴意,吴志坚,李胜涛,徐桂珍,徐玉娟.常见非发酵革兰氏阴性杆菌的分布与耐药特性分析[J].世界临床医学,2017,11(5):227-228. 被引量:4
  • 2詹爱霞,李克诚.耐碳青霉烯鲍曼不动杆菌感染治疗的实验依据[J].江西医学检验,2006,24(5):406-408. 被引量:2
  • 3汪复,张婴元.实用抗感染治疗学[M].北京:人民卫生出版社,2005:134.
  • 4LipowskiD,Rzadkiewicz E,Czekalska-Lachowicz E.Burkholderiacepacia:A new pathogen causing nosocomical infections[J].Przegl Epi-demiol,2008,62(1):7-17.
  • 5Loukil C,Saizou C,DoitC,et al.Epidemiologic investigation of Burkholde-ria cepacia acquisition in two pediatric intensive care units[J].Infect-Control hosp Epidemio,2003,24(9):707-710.
  • 6Fukuoka T, Masuda N, Takenouchi T, et al. Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media[J]. Antimicrob Agents Chemother, 1991, 35(3): 529-532. Cli.
  • 7nical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[EB/OL]. [2013-10-10]. http://ebookbrowsee. net/cl/clsi-m07-a8#.U0jDNeZWQoM.
  • 8Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, Twenty- Second Informational Supplement[EB/OL]. [2013-10- 10]. http://antimicrobianos.com.ar/ATB/wp-content/ uploads/2012/11/M 100S22E.pdf.
  • 9Calandra G, Lydick E, Carrigan J, et al. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experiences with imipenem/cilastatin[J]. Am J Med, 1988, 84(5): 911-918.
  • 10Fukuoka T, Ohya S, Narita T, et al. Activity of the carbapenem panipenem and role of the OprD (D2)protein in its diffusion through the Pseudomonas aeruginosa outer membrane[J].Antimicrob Agents Chemother, 1993, 37(2): 322-327.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部